ArticleBMJ medicine2022

Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs.

Mayookha Mitra-Majumdar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.